SUBSCRIBE
SUBSCRIBE
News   Business

Merck & Co., Inc., Ranbaxy Laboratories Drug Development Deal Called Off

January 6, 2011 | 
1 min read

ET -- US drug maker Merck & Co has terminated its nearly two-year-old alliance with Ranbaxy Laboratories to develop anti-infective medicines , which could have fetched the Indian firm USD 100 million over a period of five years.

Alliances Asia
MORE ON THIS TOPIC
Hands in black and white dropping a collection of pills on a pink background
Manufacturing
Viking Secures 1B Supply of Obesity Pill Candidate With $150M Prepayment Deal
March 11, 2025
 · 
2 min read
 · 
Annalee Armstrong
Dollar banknote cut into pieces on a yellow background
Gene therapy
Roche Absorbs $2.4B Impairment in Overhaul of Spark Gene Therapy Unit
March 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Trendy halftone collage. Concept of contracting, negotiation, contracting, favorable terms. Trendy modern retro illustration on business theme. Concept of teamwork. Vector illustration
Mergers & acquisitions
BMS Buys Abecma Partner 2seventy for $286M, Ending Cost Sharing Agreement
March 11, 2025
 · 
3 min read
 · 
Tristan Manalac
Composite photo collage of hand hold magnifier glass research examine secret object question mark secret isolated on painted background.
Editorial
This Might Be a Moot Point but the FDA’s Priority Review Vouchers Need Transparency
March 7, 2025
 · 
3 min read
 · 
Annalee Armstrong